ABPI
@abpi.org.uk
ABPI represents UK research-based pharmaceutical companies, working to make the UK the best place to research, develop and use new medicines.
ABPI's Company Logos


ABPI's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#331F4C
Port Gore
51, 31, 76
267, 42, 21
33, 59, 0, 70
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#707070
Dove Gray
112, 112, 112
0, 0, 44
0, 0, 0, 56
About ABPI
ABPI, the Association of the British Pharmaceutical Industry, is a leading organization dedicated to the development, regulation, and distribution of medicines and vaccines. With a focus on international trade, research, and development, and working in partnership with the National Health Service (NHS), ABPI strives to improve the healthcare landscape in the UK. ABPI's code of practice ensures that the pharmaceutical industry operates ethically and transparently, prioritizing patient well-being.
They value and prioritize access to medicines, recognizing their crucial role in improving patients' lives. The organization also supports research and development efforts to create a thriving environment for medicine discovery. Moreover, ABPI actively collaborates with patient organizations, healthcare professionals, and government bodies to maintain the industry's reputation and deliver medicines responsibly.
They prioritize the international trade and policy to ensure the UK remains at the forefront of healthcare advancements. By harnessing health data and utilizing the opportunities it offers, ABPI aims to support clinical trials and drive research into new medicines. Their commitment to improving healthcare outcomes is evident through their continuous efforts and dedication.
In summary, ABPI is a renowned organization that plays a pivotal role in the pharmaceutical industry. They advocate for patients, facilitate collaboration, and strive to create a sustainable and innovative healthcare system in the UK
Company type
Nonprofit
Year founded
1891
Company size
51-200 employees
Related Brands
Tags
Pharmaceutical trade association
Medicines and vaccines
NHS-industry partnerships
Clinical research
Intellectual property and regulation
